LSP 7 Cooperative UA (10% owner) purchases 1,562,500 shares of EVMN at $16.00 for $25,000,000 in cluster-buy pattern
LSP 7 Cooperative UA, a 10% shareholder in Evommune, acquired 1,562,500 shares at $16.00 on 2025-11-07, expanding its holding from 3,367,133 shares to 4,929,633 shares—a 46.4% increase in position size. This $25,000,000 transaction occurs just 5 trading days after EVMN's listing, when the company is establishing its post-IPO market valuation. The timing coincides with a broader pattern: 2 other insiders also bought within the past 14 days, suggesting coordinated conviction at the post-IPO stage. While the current price has risen to $19.52 above the transaction price of $16.00, the clustering of insider purchases across multiple parties within two weeks post-listing signals material confidence in near-term prospects. However, caution is warranted: this is a very early-stage public company, derivatives-conversion elements are present in the filing (Form 4 Table II), and the shareholder's full position cannot yet be fully assessed from available data.